ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 207 filers reported holding ARIAD PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 2.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $159,853,000 | -9.1% | 12,850,000 | 0.0% | 44.03% | +8.7% |
| Q3 2016 | $175,916,000 | +85.3% | 12,850,000 | 0.0% | 40.51% | +50.3% |
| Q2 2016 | $94,961,000 | +15.6% | 12,850,000 | 0.0% | 26.95% | +49.0% |
| Q1 2016 | $82,111,000 | +2.2% | 12,850,000 | 0.0% | 18.09% | +15.9% |
| Q4 2015 | $80,313,000 | +7.0% | 12,850,000 | 0.0% | 15.61% | -15.8% |
| Q3 2015 | $75,044,000 | -29.4% | 12,850,000 | 0.0% | 18.53% | -24.2% |
| Q2 2015 | $106,270,000 | +0.4% | 12,850,000 | 0.0% | 24.46% | +9.5% |
| Q1 2015 | $105,884,000 | +19.9% | 12,850,000 | 0.0% | 22.34% | -28.5% |
| Q4 2014 | $88,280,000 | +27.2% | 12,850,000 | 0.0% | 31.25% | +16.6% |
| Q3 2014 | $69,390,000 | -9.2% | 12,850,000 | +7.1% | 26.80% | +3.1% |
| Q2 2014 | $76,440,000 | -21.0% | 12,000,000 | 0.0% | 25.99% | -21.9% |
| Q1 2014 | $96,720,000 | +18.2% | 12,000,000 | 0.0% | 33.30% | +8.7% |
| Q4 2013 | $81,840,000 | – | 12,000,000 | – | 30.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |